Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
2.02
Dollar change
-0.06
Percentage change
-2.88
%
Index- P/E- EPS (ttm)-0.85 Insider Own61.47% Shs Outstand8.38M Perf Week-0.98%
Market Cap23.13M Forward P/E- EPS next Y-0.95 Insider Trans0.00% Shs Float4.41M Perf Month-6.05%
Income-7.24M PEG- EPS next Q-0.20 Inst Own1.36% Short Float1.42% Perf Quarter23.93%
Sales0.32M P/S72.28 EPS this Y53.59% Inst Trans257.85% Short Ratio0.37 Perf Half Y75.65%
Book/sh0.76 P/B2.66 EPS next Y-13.10% ROA-59.69% Short Interest0.06M Perf Year15.43%
Cash/sh0.39 P/C5.13 EPS next 5Y- ROE-73.89% 52W Range0.95 - 3.62 Perf YTD37.37%
Dividend Est.- P/FCF- EPS past 5Y- ROI-87.94% 52W High-44.20% Beta3.95
Dividend TTM- Quick Ratio3.06 Sales past 5Y0.00% Gross Margin42.66% 52W Low111.56% ATR (14)0.24
Dividend Ex-Date- Current Ratio3.07 EPS Y/Y TTM45.40% Oper. Margin-2256.55% RSI (14)52.13 Volatility4.85% 19.86%
Employees14 Debt/Eq0.24 Sales Y/Y TTM12989.94% Profit Margin-2251.53% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.18 EPS Q/Q55.19% Payout- Rel Volume0.44 Prev Close2.08
Sales Surprise198.50% EPS Surprise-44.44% Sales Q/Q25855.13% EarningsNov 14 AMC Avg Volume169.94K Price2.02
SMA20-0.43% SMA5014.03% SMA20024.17% Trades Volume73,986 Change-2.88%
Mar-08-24 01:15PM
12:45PM
Mar-06-24 10:45AM
09:46AM
Mar-05-24 08:00AM
08:00AM Loading…
Feb-21-24 08:00AM
Feb-06-24 08:00AM
Jan-30-24 08:00AM
Jan-23-24 08:00AM
Jan-08-24 08:00AM
Jan-05-24 09:00AM
Dec-05-23 08:00AM
Nov-30-23 08:00AM
Nov-28-23 08:00AM
Nov-15-23 08:00AM
04:01PM Loading…
Nov-14-23 04:01PM
Nov-06-23 08:00AM
Oct-10-23 08:00AM
Sep-21-23 09:35AM
Sep-19-23 08:00AM
Sep-07-23 08:00AM
Aug-14-23 05:03PM
Jul-12-23 08:00AM
Jun-15-23 08:00AM
May-22-23 08:00AM
May-15-23 08:00AM
May-01-23 08:00AM
Apr-25-23 08:00AM
Apr-05-23 08:00AM
Mar-31-23 05:52PM
08:00AM Loading…
Mar-28-23 08:00AM
Mar-24-23 08:00AM
Feb-13-23 08:00AM
Jan-24-23 08:00AM
Jan-04-23 08:00AM
Dec-19-22 11:33AM
Dec-15-22 08:30AM
Dec-01-22 08:00AM
Nov-14-22 07:30AM
Nov-10-22 08:15AM
Nov-08-22 08:00AM
Oct-25-22 09:15AM
Oct-12-22 08:15AM
Sep-28-22 08:15AM
Sep-14-22 08:15AM
Sep-06-22 01:54PM
11:28AM
Sep-01-22 12:32PM
08:15AM
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.